Clinical Trial Update: Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial of Angiogenic Cell Therapy for progressive pulmonary hypertension has been terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Angiogenic Cell Therapy

Snippet

Sponsor: Northern Therapeutics | Conditions: Hypertension,Pulmonary | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2025-01-31